[A new spasmolytic neo-octinum, in the treatment of Parkinson's syndrome].
D006801:Humans; D010276:Parasympatholytics; D010300:Parkinson Disease / Q000628:therapy*; D013566:Sympathomimetics / Q000627:therapeutic use*
D010276:Parasympatholytics; D013566:Sympathomimetics
PARALYSIS AGITANS/therapy; SYMPATHOMIMETICS/therapeutic use
Ein neues Spasmolytikum, Neo-Octinum, in der Behandlung des Parkinsonsyndroms.